g(m1)-oligosaccharide has been researched along with Disease Models, Animal in 1 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alselehdar, S; Assini, R; Cattaneo, S; Chiricozzi, E; Ciampa, MG; Di Biase, E; Fato, P; Fazzari, M; Ledeen, RW; Loberto, N; Lunghi, G; Maggioni, M; Mauri, L; Pomè, DY; Prioni, S; Sonnino, S; Valsecchi, M; Verlengia, G; Wu, G | 1 |
1 other study(ies) available for g(m1)-oligosaccharide and Disease Models, Animal
| Article | Year |
|---|---|
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1
Topics: alpha-Synuclein; Animals; Disease Models, Animal; Female; Hand Strength; Male; Mice, Inbred C57BL; Motor Activity; N-Acetylgalactosaminyltransferases; Neurotransmitter Agents; Oligosaccharides; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase | 2019 |